Kynos Therapeutics targets inflammation-driven illness

Spin-off company will focus on developing therapies in areas of inflammation and immunometabolism - News - PharmaTimes

Related Keywords

United Kingdom ,Edinburgh ,City Of ,Scotland , ,University Of Edinburgh ,Damian Mole ,Kynos Therapeutics ,Growth Investments ,Scottish Enterprise ,Kynos ,Community ,Inflammation ,